Lb Pharmaceuticals Inc · NASDAQ:LBRX
BlackRock Portfolio Management LLC reported a 5.90% stake in Lb Pharmaceuticals Inc (Schedule 13G)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock Portfolio Management LLC reported a 5.90% stake in Lb Pharmaceuticals Inc, 975,000 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G).
- Stake
- 5.90%
- Shares
- 975,000
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock Portfolio Management LLC | 5.90% | 975,000 |
Source
Related
- Lb Pharmaceuticals Inc
- BlackRock Portfolio Management LLC
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jan 21, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026